marijuana stocks news

Form 8-K for ENERTOPIA CORP.


18-Apr-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD DisclosureOn April 18, 2016, the Company announced that it is not going to pursue LOI announced on March 10, 2016.

A copy of the news release is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.(d) Exhibits.

Exhibit No. Description

99.1 Press Release dated April 18, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

INSYS Therapeutics, Inc. (INSYS) Commences Phase-2 Clinical Trial of Cannabidiol Oral Solution

Blog Exposure – INSYS Commences Phase-2 Clinical Trial of Cannabidiol Oral Solution…

 Tetra Bio-Pharma Inc. (TBPMF) Announces Plenitude Clinical Trial is Initiated

Tetra Bio-Pharma Announces Plenitude Clinical Trial is Initiated Tetra Bio-Pharma Inc. (“Tetra”…

Lifestyle Delivery Systems Inc. (LDSYF) Announces Additional Stores Carrying CannaStrips™

Lifestyle Delivery Systems Inc. Announces Additional Stores Carrying CannaStrips™ Lifestyle Delivery Systems…

GT Biopharma Inc. (GTBP) Announces 50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion Sickness

GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP.PA) announced today that the Proof-of-Concept…